Clinical Trial Update: Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006) [Phase 2]

View source ↗

Summary

Phase IIB 2-period crossover polysomnography study of MK-4305-006 in adults with primary insomnia completed; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• MK-4305-006

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Primary Insomnia | Phase 2 | Status: COMPLETED | Results posted: 2014-11-14